MeOIstPyrd is an anti-skin cancer compound that inhibits cell proliferation, migration, and spheroid formation by activating the mitochondrial intrinsic apoptotic pathway; it induces DNA damage and exerts its therapeutic effects by binding to the p53 subpocket of MDM2, blocking the p53-MDM2 interaction, stabilizing p53 through phosphorylation at Ser15, and increasing p53 half-life.